Related Topics:
Facility ID: 95688LZCRP700EU
Facility Name and Address: ALZA CORP 700 EUBANKS DRIVE VACAVILLE, CA 95688 Parent Company: JOHNSON & JOHNSON INC Industry: Pharmaceutical Preparation Manufacturing (325412) Chemical: Chloroform Reports: View TRI Facility profile report for this facility View TRI Form R submissions by this facility |
|
*You can navigate within the map with your mouse. |
Production Related Waste Management for Selected Chemical
lchemid=0000067663
Chart Options1: |
Waste Management Comparison -
Display facility comparison report for this industry and chemical
Display facility comparison report for this parent company
Pollution Prevention Activities for Selected Chemical
Reporting Year | Section 8.10: Newly Implemented Source Reduction Activity | Section 8.10: Methods to Identify Activity | Section 8.11: Optional Pollution Prevention Information* |
---|---|---|---|
2021 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA approved manufacturing process. |
|
2019 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - Used to manufacture FDA approved medication. |
|
2018 |
Barriers: B6-Barriers to P2 B6 - Pollution prevention previously implemented - additional reduction does not appear technically or economically feas
|
Barriers to P2: B6 - Pollution prevention previously implemented - additional reduction does not appear technically or economically feas - Note that minor efficiency improvements in the process have resulted in a 2% reduction in waste generation/pound of chloroform dispensed since 2014. |
|
2017 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
|
Barriers to P2: B7 - No known substitutes or alternative technologies. - FDA regulated manufacturing process |
|
2016 |
Other Barriers to Source Reduction - FDA Regulated process |
||
2015 |
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens.
|
Barriers to P2: B5 - Specific regulatory/permit burdens. - Formulation using this material is approved by FDA. Source Reduction: General Environmental Management - Overall sitewide focus on quality improvements, procedure improvements, and efficiencies resulted in less waste generated per pound of material used for production activities by about 67%. |
|
2014 |
Barriers: B7-Barriers to P2 B7 - No known substitutes or alternative technologies.
Barriers: B5-Barriers to P2 B5 - Specific regulatory/permit burdens. |
Barriers to P2: B7 - No known substitutes or alternative technologies. - Product efficacy dicated by formula used for production. Source Reduction: General Environmental Management - Procedures for sampling and general waste management established to minimize errors and waste resulting from errors. Barriers to P2: B5 - Specific regulatory/permit burdens. - Process formula is FDA approved and cannot be altered. |
|
2013 |
Other Barriers to Source Reduction - No viable source reduction options identified to date. |
||
2012 |
Other Barriers to Source Reduction - Pollution prevention previously implemented- additional reduction does not appear technically or economically feasible. |
||
2007 |
Source Reduction:: W58: Other process modifications
|
Methods to Identify SR Opportunities: T06: Employee recommendation (under a formal company program)
|